ArticleProceedings of the National Academy of Sciences of the United States of America2026

Engineering chimeric antigen receptor CD4 T cells for Alzheimer's disease.

Pavle Boskovic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.